Pure Global AI
NCT06395272Not yet recruiting

Effects of Proprioceptive Sensitivity Stimulation Via the SURA Electrodevice on Kinematics, Kinetics and Spatiotemporal Parameters of Gait.

Effects of Proprioceptive Sensitivity Stimulation Via the SURA Electrodevice on Kinematics, Kinetics and Spatiotemporal Parameters of Gait: a Pilot Study.
Facultat de ciencies de la Salut Universitat Ramon LlullClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Stroke
Drug/Device/Intervention
SURA
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Facultat de ciencies de la Salut Universitat Ramon Llull
Location
Barcelona, Spain
Timeline & enrollment
Phase
N/A
Start date
May 05, 2024
End date
Dec 20, 2024
Enrollment
30 participants
Primary outcome

The kinematics, kinetics and spatio-temporal parameters of gait.

Summary

Recovery of function in people with central nervous system (CNS) injury after stroke is very
 much like a relearning process that takes advantage of preserved sensorimotor circuits.
 Relearning can be optimised by providing appropriate proprioceptive (or deep sensory)
 information to the spinal cord with the aim of maximally engaging the preserved neural
 circuits. The development of the SURA electrodevice offers this sensitive input mechanism,
 within the Botton Up therapies. And through research on its use, the impact on the different
 dimensions related to gait and its components, and the translation to the functional reality
 of the person, will be evaluated.

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionFamily history of strokeCerebral infarction, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06395272
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06395272 through Pure Global AI's free database. This phase not specified trial is sponsored by Facultat de ciencies de la Salut Universitat Ramon Llull and is currently Not yet recruiting. The study focuses on Stroke. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.